Arcus Biosciences, Inc. (NYSE: RCUS) last traded at $22.51, down 7.52% on the session. The quote above updates while this page is open; the figures below are drawn from Arcus Biosciences, Inc.’s own filings and are restated only when a new one is published.
Arcus Biosciences, Inc. trades on NYSE under the ticker RCUS. Its market capitalisation is $2.87 billion.
Valuation measures for Arcus Biosciences, Inc., derived from the latest quote and its most recent SEC filing.
| Market cap | $2.87B |
|---|---|
| Enterprise value | $3.18B |
| Price / sales | 24.50 |
| Price / book | 6.18 |
| Beta | 1.66 |
Trailing-twelve-month figures tagged in Arcus Biosciences, Inc.'s XBRL filings with the SEC.
| Revenue (TTM) | $117.00M |
|---|---|
| Net income (TTM) | -$460.00M |
| EPS (TTM) | -$3.89 |
| Operating margin | -415.38% |
| Return on equity | -99.14% |
| Cash | $150.00M |
Range and volume for RCUS over the past 52 weeks.
| 52-week high | $31.74 |
|---|---|
| 52-week low | $15.38 |
| Volume | 1.39M |
| Average volume | 1.35M |
| Previous close | $24.34 |
Invest a chosen dollar amount in Arcus Biosciences, Inc. with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell RCUS.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.